J Breast Cancer.  2011 Sep;14(3):251-252.

Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?

• Lee JE
• Nam SJ

Abstract

No abstract available.

MeSH Terms

Breast
Breast Neoplasms
Neoplastic Stem Cells

Reference

1. Wu H, Li R, Hang X, Yan M, Niu F, Liu L, et al. Can CD44+/CD24- tumor cells be used to determine the extent of breast cancer invasion following neoadjuvant chemotherapy? J Breast Cancer. 2011. 14:175–180.

2. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003. 36:Suppl 1. 59–72.

3. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009. 15:907–913.

4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003. 100:3983–3988.

5. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007. 1:555–567.

6. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res. 2010. 16:45–55.

7. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol. Epub 2011 Jun 16. DOI: 10.1136/jcp.2011.090456.

8. Davidson NE, Morrow M. Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer. J Natl Cancer Inst. 2005. 97:159–161.

9. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008. 100:672–679.